scPharmaceuticals (NASDAQ:SCPH) Receives Buy Rating from HC Wainwright
scPharmaceuticals (NASDAQ:SCPH – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $18.00 target price on the stock. HC Wainwright’s price objective indicates a potential upside of 447.11% from the company’s previous close. Separately, Craig Hallum reduced […]
scPharmaceuticals (NASDAQ:SCPH – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $18.00 target price on the stock. HC Wainwright’s price objective indicates a potential upside of 447.11% from the company’s previous close. Separately, Craig Hallum reduced […]
